Details for 2019165074

Up to date per 03.04.2026

Actions

Title / Product Name

EDARAVONE ZUR BEHANDLUNG VON AMYOTROPHER LATERALSKLEROSE ODER VERHINDERUNG DES FORTSCHREITENS VON AMYOTROPHER LATERALSKLEROSE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019165074

EP Publication Number

3520788

E-Number

1885104

Language

PCT Number

Publication Date

07.08.2019 A

11.02.2026 B1

Registration Date

11.02.2026

AT Publication Date

15.03.2026

Application Date

05.09.2012

Registration Number

Priorities

05.09.2011

2011192288

IPC

A61K 31/4152 20060101AFI20250304BHEP

Maximum Duration of Protection

05.09.2032

Owner

Mitsubishi Tanabe Pharma Corporation2-10, Dosho-machi 3-chome Chuo-ku Osaka-shi Osaka 541-8505JP

Representative

No representatives present

Inventor

YONEOKA, TakatomoMitsubishi Tanabe Pharma Corporation 3-2-10, Dosho-machi, Chuo-ku, Osaka 541-8505JP

Information about Fees